Tuesday, November 7, 2017

FDA Warns Chinese Firm for Confusing API in OTC Drug

Regulatory Focus-7 hours ago
The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent last Monday to China-based Guangdong Zhanjiang Jimin ...
Post a Comment